NEW YORK, Oct. 31, 2025 /PRNewswire/ -- Metsera, Inc. (MTSR) ("Metsera" or the "Company") today issued the following statement in response to litigation filed against the Company by Pfizer: "Metsera ...
IRVINE, Calif.--(BUSINESS WIRE)-- Masimo (NASDAQ: MASI) today issued the following statement in response to the jury verdict announced in the U.S. District Court for the Central District of California ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback